Genes and obesity: A cause and effect relationship;Genes y obesidad: Una relación de causa-consecuencia

Endocrinologia y Nutricion

Volumn 58, Issue 9, 2011, Pages 492-496

  González Jiménez, Emilio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Genes; Inflammation; Obesity

Indexed keywords

ADIPOCYTE; ADIPOSE TISSUE; CALORIC INTAKE; CAUSAL ATTRIBUTION; CELL DIFFERENTIATION; CELL GROWTH; DNA POLYMORPHISM; ENERGY EXPENDITURE; GENE EXPRESSION; GENE INTERACTION; HUMAN; INFLAMMATION; INSULIN METABOLISM; LIFESTYLE MODIFICATION; OBESITY; SEDENTARY LIFESTYLE; SHORT SURVEY; SIGNAL TRANSDUCTION;

HUMANS; OBESITY; PREVALENCE;

EID: 82755182686     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2011.06.004     Document Type: Short Survey

References (39)

1. World Health Organization Report of a Joint WHO/FAO Expert Consultation on Diet, Nutrition and the prevention of chronic diseases 2003, Technical Report Series, Geneva.
2. Aranceta J., Pérez C., Serra L.L., Bellido D., De la Torre M.L., Formiguera X., et al. Prevention of owerweight and obesity: A Spanish approach. Public Health Nutr 2007, 10:1187-1193.
3. Hurt R.T., Kulisek C., Buchanan L.A., McClave S.A. The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists. Gastroenterol Hepatol 2010, 6:780-792.
4. Dorresteijn J.A., Visseren F.L., Van Den Meiracker A.H., Spiering W. Obesity related hypertensión. Ned Tijdschr Geneeskd 2011, 154:1945.
5. Tesauro M., Canale M.P., Rodia G., Di Daniele N., Lauro D., Scuteri A., Cardillo C. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract 2011, 7:653182.
6. Guarnieri G., Zanetti M., Vinci P., Cattin M.R., Pirulli A., Barazzoni R. Metabolic syndrome and chronic kidney disease. J Ren Nutr 2010, 20:19-23.
7. Tinahones F.J., Garrido L., Miranda M., García J.M., Macias M., Ceperuelo V., et al. Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes Surg 2010, 20:1559-1567.
8. Silventoinen K., Kaprio J. Genetics of tracking of body mass index from birth to late middle age: evidence from twin and family studies. Obes Facts 2009, 2:196-202.
9. Gil A. Obesidad y genes. Vox Paediatrica 2002, 10:41-46.
10. Bell C.G., Walley A.J., Froguel P. The genetics of human obesity. Nat Rev Genet 2005, 6:221-234.
11. Allison D.B., Kaprio J., Korkeila M., Koskenvuo M., Neale M.C., Kayakawa K. The heritability of body mass index hmong an international sample of monozygotic twins reared apart. Int J Obes 1996, 20:501-506.
12. Rankinen T., Zuberi A., Chagnon Y.C., Weisnagel S.J., Argyropoulos G., Walts B., et al. The human obesity gene map: the 2005 update. Obesity 2006, 14:529-644.
13. Hossain P., Katar B., El Vahas M. Obesity and diabetes in the developing world. Agrowing challenge. N Eng J Med 2007, 356:213-215.
14. Yach D., Stuckler D., Brownell K.D. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006, 12:62-66.
15. Serra-Majem L., Ribas Barba L., Aranceta Bartrina J. Obesidad infantil y juvenil en España. Resultados del estudio ENKID (1998-2000). Med Clin (Barc) 2003, 121:725-732.
16. González E., Aguilar M.J., García C.J., García P.A., Padilla C.A., Álvarez J. Epidemiological study of nursing on the prevalence of overweight, obesity and its association with hypertension in a population of students in the city of Granada and its province. Nutr Clin Diet Hosp 2010, 30:42-50.
17. Braud S., Ciufolini M., Harosh Energy expenditure genes or energy absorption genes: a new target for the treatment of obesity and Type II diabetes. Future Med Chem 2010, 2:1777-1783.
18. Farooqi I.S. Genetic, molecular and physiological insights into human obesity. Eur J Clin Invest 2011, 41:451-455.
19. Pérusse L., Rankinen T., Zuberi A., Chagnon Y.C., Weisnagel S.J., Argyropoulos G., et al. The human obesity gene map: the 2004 update. Obes Res 2005, 13:381-490.
20. Chagnon Y.C., Rankinen T., Snyder E.E., Weisnagel S.J., Perusse L., Bouchard C. The human obesity gene map: the 2002 update. Obes Res 2003, 11:313-367.
21. Sims E.A.H. Are the persons who are obese, but metabolically healthy?. Metabolism 2001, 50:1499-1504.
22. Cheverud J.M., Lawson H.A., Fawcett G.L., Wang B., Pletscher L.S., Fox R., et al. Diet-dependent genetic and genomic imprinting effects on obesity in mice. Obesity 2011, 19:160-170.
23. Barsh G.S., Farooqi S., O'Rahilly S. Genetics of body-weight regulation. Nature 2000, 404:644-651.
24. Larsen L.H., Echwald S.M., Sorensen T.I., Andersen T., Wulff B.S., Pedersen O. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab 2005, 90:219-224.
25. Pankov LuA. Genetic variations in energy balance regulation. Biomed Khim 2010, 56:152-167.
26. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
27. Rodríguez-López R., González-Carpio M., Serrano M.V., Torres G., García de Cáceres M.T., Herrera T., et al. Association of FTO gene polymorphisms and morbid obesity in the population of Extremadura (Spain). Endocrinol Nutr 2010, 57:203-209.
28. Loos R.J., Lindgren C.M., Wheeler E., Zhao J.H., Prokopenko I., Inouve M., et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008, 40:768-775.
29. Gerken T., Girard C.A., Tung Y.C., Webby C.J., Saudek V., Hewitson K.S., et al. The obesity associated FTO gene encodes a 2-oxoglutarate dependent nucleic acid demethylase. Science 2007, 318:1469-1472.
30. Wardle J., Lewellyn C., Sanderson S., Plomin R. The FTO gene and measured food intake in children. Int J Obes 2009, 33:42-45.
31. Rankinen T., Perusse L., Weisnagel S.J., Snyder E.E., Chagnon Y.C., Bouchard C. The human obesity gene map: the 2001 update. Obes Res 2002, 10:196-243.
32. Nativio D.G. The genetics, diagnosis, and management of Prader-Willi syndrome. J Pediatr Health Care 2002, 16:298-303.
33. Deeble V.J., Roberts E., Jackson A., Lench N., Karbani G., Woods C.G. The continuing failure to recognise Alstrom syndrome and further evidence of genetic homogeneity. J Med Genet 2000, 37:219.
34. Collin G.B., Marshall J.D., Ikeda A., So W.V., Russell-Eggitt I., Maffei P., et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet 2002, 31:74-78.
35. Farooqi I.S. Genetic and hereditary aspects of childhood obesity. Best Pract Res Clin Endocrinol Metab 2005, 19:635-643.
36. Jenkins D., Baynam G., De Catte L., Elcioglu N., Gabbett M.T., Hudgins L., et al. Carpenter syndrome: extended RAB23 mutation spectrum and analysis of nonsensemediated mrna decay. Hum Mutat 2011, 32:2069-2078.
37. Katsanis N. The oligogenic properties of Bardet-Biedl syndrome. Hum Mol Genet 2004, 13:65-71.
38. Mykytyn K., Nishimura D.Y., Searby C.C., Beck G., Bugge K., Haines H.L., et al. Evaluation of complex inheritance involving the most common Bardet-Bield syndrome locus (BBS1). Am J Hum Genet 2003, 72:429-437.
39. Gil Hernández A. Genética de la obesidad humana. Nutr Clin Med 2007, 1:163-173.